World Solve

Patients who've had one dangerous blood clot are at ongoing risk of another, and current prevention relies mainly on long-term blood thinners that carry their own risks. A more targeted, lower-risk prevention method remains needed.

Many cancer survivors continue to experience pain long after their cancer treatment concludes, and this pain is often undertreated because it's assumed to have resolved along with the disease. Better long-term pain management for survivors remains an overlooked need.

Research shows a strong link between childhood trauma and adult physical illness, but effective, scalable prevention and early intervention remain limited. Closing this gap could improve both mental and physical health outcomes across entire populations.

Extended time in a hospital bed, especially in intensive care, can cause significant muscle loss that affects recovery and long-term function. Better prevention methods during hospitalization remain underdeveloped.

A persistent gap exists in realizing practical, scalable solutions for technologies for the safe and efficient long-term storage of renewable energy at seasonal scales. Scientific understanding, engineering readiness and institutional capacity remain insufficient to translate promising concepts into durable impact under real-world constraints of cost, skills and governance.

A subset of patients with chronic hives don't respond well to typical antihistamine treatment, leaving them with persistent, disruptive symptoms and few further options. More effective alternatives remain limited.

Childhood asthma rates have risen substantially, but why some children develop severe, persistent symptoms while others exposed to similar triggers don't remains only partly understood. A clearer answer could improve both prevention and treatment.

Some patients continue experiencing symptoms long after completing standard treatment for Lyme disease, and doctors disagree on both the cause and the best way to treat this lingering illness. Resolving this uncertainty remains a significant unmet need.

Many people who experience one episode of depression go on to experience another, and current treatments don't reliably prevent this recurrence. Better long-term prevention strategies remain an important gap in mental health care.

Stomach cancer often causes no clear symptoms until it has progressed significantly, particularly in regions without routine screening programs. Earlier, more accessible detection could substantially improve survival outcomes.

Osteoarthritis treatment currently focuses on managing pain and preserving remaining function rather than restoring lost cartilage. A regenerative treatment could transform care for one of the most common causes of chronic pain in older adults.

Repeated gout attacks can cause lasting joint damage even with treatment, and prevention still relies mainly on managing uric acid levels rather than fully eliminating the underlying risk. A more definitive prevention method remains unmet.

Narcolepsy causes sudden, uncontrollable sleep episodes that significantly disrupt daily life, and current treatments manage symptoms rather than address the underlying cause. A true cure remains undiscovered.

This parasitic disease affects millions in tropical and subtropical regions, but effective treatment remains expensive, difficult to access, or logistically challenging for many affected communities. Closing this access gap remains unresolved.

This rare but severe condition can develop rapidly after childbirth, and delays in recognition and treatment can have dangerous consequences for both mother and baby. Faster, more reliable detection and treatment protocols remain an urgent unmet need.

Malnutrition rates spike dramatically in areas affected by war, but delivering treatment consistently in unstable, hard-to-reach regions remains a persistent logistical and medical challenge. Solving this requires both medical and access innovation.

Persistent dizziness and balance problems can severely affect quality of life, yet treatment for many chronic cases remains limited and inconsistent. A more reliable, targeted treatment approach remains undeveloped.

Even with strict sterile procedures, a portion of surgical patients still develop infections afterward, extending recovery and sometimes causing serious complications. Reducing this risk further remains an ongoing surgical challenge.

The vast majority of autoimmune disease diagnoses occur in women, and the biological reasons behind this imbalance remain only partially understood. A clearer answer could open new treatment approaches for both sexes.

Highly effective hepatitis C treatments exist, but cost and healthcare access still prevent many infected people worldwide from receiving them. Expanding affordable access remains the primary barrier rather than the science itself.